Answers are grounded in this paper and cite their sources.
Background Pathological scarring remains a significant source of patient morbidity, with conventional treatments like intralesional injections and laser therapy limited by pain, invasiveness, and inconsistent outcomes. Emerging evidence suggests that direct current (DC) microcurrent stimulation may modulate scar tissue remodeling through bioelectrical mechanisms. This pilot study evaluates the efficacy of DC microcurrent therapy in reducing scar depth using high-resolution 17 MHz 3D ultrasound—a novel, objective metric for scar assessment. Methods Seventeen patients with symptomatic post-surgical scars underwent bilateral DC microcurrent stimulation (Dolphin Neurostim device, FDA-cleared for pain management) applied at 30-second intervals along the scar length. Polarity was alternated (-/+ configuration) to optimize current penetration. Pre- and post-treatment scar depth was quantified via volumetric linear probe ultrasound (GE Healthcare), with measurements taken at identical anatomical sites. Results A statistically significant mean reduction in scar depth of 0.447 mm (23.8%) was observed post-treatment (95% CI: 0.264–0.630 mm, p<0.001). Secondary outcomes included patient-reported improvements in pain and range of motion, suggesting functional tissue softening. Conclusion High-frequency 3D ultrasonography objectively demonstrates DC microcurrent's capacity to reduce scar depth finding with implications for improving intralesional therapy accessibility in deeper scars. Further studies need to be undertaken to correlate morphological changes with long-term symptom relief and explore mechanisms linking bioelectrical modulation to extracellular matrix remodeling.
No takes yet. Share an insight, caveat, or question.
Gokal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: